While large language models (LLMs) hold promise for transforming clinical healthcare, current comparisons and benchmark evaluations of large language models in medicine often fail to capture real-world efficacy. Specifically, we highlight how key discrepancies arising from choices of data, tasks, and metrics can limit meaningful assessment of translational impact and cause misleading conclusions. Therefore, we advocate for rigorous, context-aware evaluations and experimental transparency across both research and deployment.

Artificial intelligence (AI) is transforming traditional medicine, particularly in radiology. Its integration across patient care stages has made it increasingly ubiquitous. The European Union’s (EU) AI Act will additionally regulate AI-enabled solutions within the EU. However, without standardized guidelines, the Act’s flexibility poses practical challenges for providers and deployers, leading to inconsistencies in meeting requirements for high-risk systems like radiology AI, potentially impacting patients’ fundamental rights and safety.

Emerging evidence suggests generative artificial intelligence (AI) may offer potential for autoimmune and rheumatic disease care, moving beyond traditional narrow AI applications to produce contextualized clinical content to support a wide spectrum of medical tasks. This article explores generative AI applications across autoimmune and rheumatologic clinical care, research, and administrative domains. However, significant implementation challenges remain, including clinical validation, model interpretability, data integration complexities, and evolving regulatory frameworks.

Although still at a nascent state, quantum computing promises advances in healthcare, from drug discovery to personalised treatments. But it also threatens current cryptographic systems that protect medical data and infrastructure. The concept of “Q-Day” highlights risks such as “harvest now, decrypt later” attacks, with particular concerns for medical devices and sensitive applications in fields like femtech. Preparing for this future requires the rapid adoption of post-quantum cryptography, the coordination of time-phased and scalable “technology rollout” strategies, and revised regulatory frameworks to safeguard patient safety, privacy, and trust.